Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer

Area of Science:

• Molecular Biology
• Epigenetics
• Oncology

Background:

• N6-methyladenosine (m6A) is the most prevalent internal modification on eukaryotic messenger RNA (mRNA).
• m6A regulates crucial cellular processes including self-renewal, differentiation, invasion, and apoptosis.
• Dysregulation of m6A methylation is linked to abnormal RNA metabolism and tumorigenesis.

Purpose of the Study:

• To review recent advancements in m6A RNA methylation research.
• To investigate the role of m6A methylation in the occurrence and development of bladder cancer (BC).

Main Methods:

• Literature review of m6A RNA methylation.
• Analysis of m6A's regulatory mechanisms in gene expression.
• Examination of m6A's involvement in bladder cancer pathogenesis.

Main Results:

• m6A modification influences gene expression by affecting mRNA metabolism.
• m6A methyltransferases catalyze m6A formation, impacting protein binding and RNA processing.
• Aberrant m6A patterns are implicated in bladder cancer progression.

Conclusions:

• m6A RNA methylation plays a significant role in regulating cellular functions.
• Understanding m6A's role in bladder cancer offers potential therapeutic targets.
• Further research into m6A mechanisms is crucial for advancing BC treatment.